Market revenue in 2023 | USD 2,433.6 million |
Market revenue in 2030 | USD 5,156.4 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 74.15% in 2023. Horizon Databook has segmented the Brazil precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
In Brazil, genomic technology and research have been gradually adopted in medical research, clinical practices, and genome-wide association studies in genetic epidemiology. The Brazilian Initiative on Precision Medicine (BIPMed), developed by the São Paulo State Research Foundation (FAPESP) in November 2018, aims to offer public access to genomic and phenotypic data in Brazil as well as in other regions.
It is based on a software platform developed by following the guidelines of Global Alliance for Genomics and Health, thus it is the first platform of its kind in Latin America. A large number of scientists and clinicians implement this data to share and gain information about several aspects of human health and genomic medicine.
It also supports training in the areas of computational biology, human molecular genetics, and others. Therefore, BIPMed plays an important role in the development of personalized medicine, enabling a significant number of advancements in healthcare and research in Brazil.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Brazil precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account